Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial

• Үндсэн зохиолчид: Enikö Sonkoly (Зохиогч), Julia-Tatjana Maul (Зохиогч), Matteo Megna (Зохиогч), Patricia Gorecki (Зохиогч), Edmée Crombag (Зохиогч), Jozefien Buyze (Зохиогч), Laura Savage (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Medical Journals Sweden, 2024-03-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Scalp psoriasis affects approximately 80% of patients with psoriasis and can negatively impact their quality of life. This post hoc analysis of the VOYAGE 2 Phase III randomized clinical trial evaluated scalp response to guselkumab treatment and its association with skin response and patient-reporte...